Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

IMPORTANCE: The 2013/2014 American Society of Clinical Oncology and College of American Pathologists (ASCO-CAP) guidelines for HER2 testing by fluorescence in situ hybridization (FISH) designated an “equivocal” category (average HER2 copies per tumor cell ≥4-6 with HER2/CEP17 ratio <2.0) to be re...

Descripción completa

Detalles Bibliográficos
Autores principales: Press, Michael F., Seoane, Jose A., Curtis, Christina, Quinaux, Emmanuel, Guzman, Roberta, Sauter, Guido, Eiermann, Wolfgang, Mackey, John R., Robert, Nicholas, Pienkowski, Tadeusz, Crown, John, Martin, Miguel, Valero, Vicente, Bee, Valerie, Ma, Yanling, Villalobos, Ivonne, Slamon, Dennis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439848/
https://www.ncbi.nlm.nih.gov/pubmed/30520947
http://dx.doi.org/10.1001/jamaoncol.2018.6012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439848/
https://www.ncbi.nlm.nih.gov/pubmed/30520947
http://dx.doi.org/10.1001/jamaoncol.2018.6012

Ejemplares similares